FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Imrich Blasko

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Geographic Areas

Austria

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Imrich Blasko; K Heinz Tragl; M Hinterberger; Susanne Jungwirth; Georg Kemmler; Wolfgang Krampla; T Leitha; P Fischer
Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort.
Imrich Blasko; Georg Kemmler; Susanne Jungwirth; Ildiko Wichart; Silvia Weissgram; Kurt A Jellinger; Karl-Heinz Tragl; Peter Fischer
Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors.
Imrich Blasko; Susanne Jungwirth; Kurt A Jellinger; Georg Kemmler; Wolfgang Krampla; Silvia Weissgram; Ildiko Wichart; Karl-Heinz Tragl; Hartmann Hinterhuber; Peter Fischer
Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Imrich Blasko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Imrich Blasko; K Heinz Tragl; M Hinterberger; Susanne Jungwirth; Georg Kemmler; Wolfgang Krampla; T Leitha; P Fischer
Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort.
The journal of nutrition, health & aging 2012;16(8):687-94.
2011: Imrich Blasko; Georg Kemmler; Susanne Jungwirth; Ildiko Wichart; Silvia Weissgram; Kurt A Jellinger; Karl-Heinz Tragl; Peter Fischer
Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(5):663-72.
2008: Imrich Blasko; Susanne Jungwirth; Kurt A Jellinger; Georg Kemmler; Wolfgang Krampla; Silvia Weissgram; Ildiko Wichart; Karl-Heinz Tragl; Hartmann Hinterhuber; Peter Fischer
Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
Journal of psychiatric research 2008;42(11):946-55.
2008: Josef Marksteiner; Michael Pirchl; Celine Ullrich; Harald Oberbauer; Imrich Blasko; Wolfgang Lederer; Hartmann Hinterhuber; Christian Humpel
Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
Pharmacology 2008;82(3):214-20.
2008: Imrich Blasko; Kurt A Jellinger; Georg Kemmler; Wolfgang Krampla; Susanne Jungwirth; Ildiko Wichart; Karl-Heinz Tragl; Peter Fischer
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Neurobiology of aging 2008;29(1):1-11.
2007: Imrich Blasko; Gabriele Knaus; Elisabeth Weiss; Georg Kemmler; Christiana Winkler; Gerda Falkensammer; Andrea Griesmacher; Reinhard Wurzner; Josef Marksteiner; Dietmar Fuchs
Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.
Journal of psychiatric research 2007;41(8):694-701.
2006: Imrich Blasko; Wolfgang Lederer; Harald Oberbauer; Thomas Walch; Georg Kemmler; Hartmann Hinterhuber; Josef Marksteiner; Christian Humpel
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias.
Dementia and geriatric cognitive disorders 2006;21(1):9-15.
2005: Imrich Blasko; Georg Kemmler; Wolfgang Krampla; Susanne Jungwirth; Ildiko Wichart; Kurt A Jellinger; Karl-Heinz Tragl; Peter Fischer
Plasma amyloid beta protein 42 in non-demented persons aged 75 years: effects of concomitant medication and medial temporal lobe atrophy.
Neurobiology of aging 2005;26(8):1135-43.
2004: Imrich Blasko; Thomas Bodner; Gabriele Knaus; Thomas Walch; Andreas Monsch; Hartmann Hinterhuber; Josef Marksteiner
Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions.
Pharmacology 2004;72(1):1-5.
2004: Imrich Blasko; Michaela Stampfer-Kountchev; Peter Robatscher; Robert Veerhuis; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Aging cell 2004;3(4):169-76.
2004: Imrich Blasko; R Beer; Marina Bigl; Jenny Apelt; Gerhard Franz; D Rudzki; Gerhard Ransmayr; Andreas Kampfl; Reinhard Schliebs
Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1).
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(4):523-36.
2003: Imrich Blasko; Beatrix Grubeck-Loebenstein
[Vaccination against Alzheimer disease?].
Wiener klinische Wochenschrift 2003;115(9):279-80.
2003: Imrich Blasko; Beatrix Grubeck-Loebenstein
Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Drugs & aging 2003;20(2):101-13.
2002: Maria Saurwein-Teissl; Thomas L Lung; Florentine Marx; Claudio Gschösser; Esther Asch; Imrich Blasko; Walther Parson; Günther Böck; Diether Schönitzer; Emanuelle Trannoy; Beatrix Grubeck-Loebenstein
Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(11):5893-9.
2001: Imrich Blasko; A Apochal; G Boeck; Tobias Hartmann; Beatrix Grubeck-Loebenstein; Gerhard Ransmayr
Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
Neurobiology of disease 2001;8(6):1094-101.
2001: Imrich Blasko; Gerhard Ransmayr; Robert Veerhuis; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
Does IFNgamma play a role in neurodegeneration?
Journal of neuroimmunology 2001;116(1):1-4.
2000: Imrich Blasko; Robert Veerhuis; Michaela Stampfer-Kountchev; Maria Saurwein-Teissl; Piet Eikelenboom; Beatrix Grubeck-Loebenstein
Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.
Neurobiology of disease 2000;7(6 Pt B):682-9.
2000: Maria Saurwein-Teissl; Imrich Blasko; K Zisterer; Ber Neuman; B Lang; Beatrix Grubeck-Loebenstein
An imbalance between pro- and anti-inflammatory cytokines, a characteristic feature of old age.
Cytokine 2000;12(7):1160-1.
2000: Imrich Blasko; M Wagner; N Whitaker; Beatrix Grubeck-Loebenstein; P Jansen-Dürr
The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53.
FEBS letters 2000;470(2):221-5.
2000: Beatrix Grubeck-Loebenstein; Imrich Blasko; Florentine Marx; I Trieb
Immunization with beta-amyloid: could T-cell activation have a harmful effect?
Trends in neurosciences 2000;23(3):114.
2000: Georg Wick; P Jansen-Dürr; P Berger; Imrich Blasko; Beatrix Grubeck-Loebenstein
Diseases of aging.
Vaccine 2000;18(16):1567-83.
2000: Imrich Blasko; Arpad Sztankay; Peter Lukas; Beatrix Grubeck-Loebenstein
Decreased thyroid peroxidase expression in cultured thyrocytes after external gamma irradiation.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(2):138-41.
1999: Florentine Marx; Imrich Blasko; K Zisterer; Beatrix Grubeck-Loebenstein
Transfected human B cells: a new model to study the functional and immunostimulatory consequences of APP production.
Experimental gerontology 1999;34(6):783-95.
1999: Imrich Blasko; Florentine Marx; Beatrix Grubeck-Loebenstein; J Marksteiner
Abnormalities of amyloid beta precursor protein expression in platelets of patients with Alzheimer disease: do we understand them well enough?
Archives of neurology 1999;56(7):889-91.
1999: Florentine Marx; Imrich Blasko; Beatrix Grubeck-Loebenstein
Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
Archivum immunologiae et therapiae experimentalis 1999;47(4):205-9.
1999: Imrich Blasko; Florentine Marx; E Steiner; Tobias Hartmann; Beatrix Grubeck-Loebenstein
TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(1):63-8.
1998: Florentine Marx; Imrich Blasko; M Pavelka; Beatrix Grubeck-Loebenstein
The possible role of the immune system in Alzheimer's disease.
Experimental gerontology 1998;33(7-8):871-81.
1998: A Schwingshackl; Imrich Blasko; E Steiner; P Pozzilli; M G Cavallo; P Berger; Beatrix Grubeck-Loebenstein
Sex steroids do not prevent amylin-induced apoptosis in human cells.
Experimental cell research 1998;241(1):265-8.
1998: E Niederwolfsgruber; TL Schmitt; Imrich Blasko; K Trieb; MM Steger; C Maczek; J Hager; K Bobak; E Steiner; Beatrix Grubeck-Loebenstein
The production of the Alzheimer amyloid precursor protein (APP) in extraneuronal tissue does not increase in old age.
The journals of gerontology. Series A, Biological sciences and medical sciences 1998;53(3):B186-90.
1997: Imrich Blasko; TL Schmitt; E Steiner; K Trieb; Beatrix Grubeck-Loebenstein
Tumor necrosis factor alpha augments amyloid beta protein (25-35) induced apoptosis in human cells.
Neuroscience letters 1997;238(1-2):17-20.